Phase 3 Trial of Nemolizumab in Patients with Prurigo NodularisShawn G. Kwatra, Sonja Ständer, C. Paul et al.|New England Journal of Medicine|2023Cited by 184
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trialsJonathan I. Silverberg, Christophe Piketty, Andreas Wollenberg et al.|The Lancet|2024Cited by 144